Autres langues Renovaro Inc.

Actions

RENB

US29350E1047

Temps Différé Nasdaq Autres places de cotation 18:03:27 02/05/2024			Varia. 5j.	Varia. 1 janv.
1,47 ^USD	0,00%		-13,53%	-53,63%

24/04	RenovaroCube, filiale de Renovaro, modifie l'accord d'acquisition de 100% des parts de Cyclomics	MT
18/04	Renovaro Inc. annonce la nomination de Geert Kazemier, MD, PhD, en tant que nouveau président de son conseil scientifique consultatif	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Renovaro : Material Event - Form 8-K	11:10
Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics	30/04
Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics	30/04
RENOVARO - RENOVAROCUBE TO ACQUIRE 100% OWNERSHIP OF CYCLOMICS, REINFORCING CUTTING-EDGE CANCER DIAGNOSTICS PARTNERSHIP	25/04
Renovaro's RenovaroCube Amends Agreement to Acquire 100% Stake in Cyclomics	24/04
RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership	24/04
Renovaro Inc. Proudly Announces the Appointment Of Professor Dr. Geert Kazemier as the Chairman of its Scientific Advisory Board, A Move That Heralds a New Era of Innovation and Progress in its Mission to Reshape Cancer Screening, Diagnosis, and Patient Care	18/04
Renovaro Inc. Announces Geert Kazemier, MD, PhD, as the New Chairman of its Scientific Advisory Board	18/04
Renovaro Inc. Appoints Simon Tarsh as Interim Chief Financial Officer	13/03
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Renovaro Biosciences Inc. - RENB	12/03
Renovaro Inc. Announces Resignation of Luisa Puche as Chief Financial Officer, Effective as of March 21, 2024	05/03
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Renovaro Biosciences Inc. - RENB	03/03
ROSEN, LEADING INVESTOR COUNSEL, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation - RENB	25/02
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Renovaro Biosciences Inc. - RENB	24/02
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation - RENB	17/02
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Renovaro Biosciences Inc. - RENB	16/02
Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace	15/02
Renovaro Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	14/02
Renovaro Inc. Announces Board Changes	14/02
Sector Update: Health Care Stocks Gain Late Afternoon	14/02

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Renovaro Inc.

Actions

RENB

US29350E1047

Autres langues

Filtres